Do you screen for sleep disorders in patients with psychiatric conditions? Symptom overlap can mean that sleep disorders such as obstructive sleep apnea are overlooked in patients with posttraumatic stress disorder and mood disorders. Read this CME article to learn about screening and evaluation.

When evaluating an older patient for possible dementia, do you order neuroimaging? Work through this CME case to learn about an 87-year-old woman who presented with her family to Banner Alzheimer’s Institute for evaluation and treatment of cognitive impairment.

Have you considered how conditions such as atopic dermatitis, acne, vitiligo, psoriasis, and alopecia affect your patients? Skin disease can be associated with anxiety, anger, depression, social isolation, and low self-esteem. Read this CME journal article to learn about recognizing and treating psychological problems in patients with skin diseases and communicating with patients in a culturally competent manner.

When you suspect that a patient is fabricating his or her illness, how do you proceed? Read this CME article to learn more about the warning signs, differential diagnosis, and management of factitious disorder.

Wernicke’s encephalopathy results from thiamine deficiency and, if untreated, can lead to significant neurologic sequelae or death. Did you know that autopsy reports indicate that three-fourths of Wernicke’s encephalopathy cases were not diagnosed before death? Read this CME article to learn about how you can better diagnose and treat this medical emergency.

Research on behavioral activation (BA) teletherapy is limited. Learn about a brief BA teletherapy program for depression and anxiety in a study describing results among low-income, real-world primary care patients.

Combat exposure has been linked to PTSD and other mental health conditions, but is it also linked to physical health conditions? Read this CME article to learn about how mental and physical conditions differ between veterans with and without combat exposure as well as between younger and older veterans with combat exposure.

The symptoms of dementia and depression frequently overlap. What are the best steps to take to differentiate between dementia and depression? Follow along with this case report to learn more about the diagnosis and treatment of a 50-year-old woman with cognitive impairment, bipolar II disorder, and a family history of Alzheimer's disease.

It is crucial that we find ways to support medication adherence for patients with schizophrenia. Long-acting injectable antipsychotic (LAI) medications are an option. In this CME study, the authors retrospectively assessed variables that factor into an individual’s adherence to LAIs.

Much attention has been paid in recent years to increasing the recognition and treatment of mental illnesses in the primary care setting, but what about the reverse? In psychiatric inpatient settings, can the screening, diagnosis, and treatment of chronic medical comorbidities be improved? Read this CME article to learn more.

When your patients' depressive episodes have not fully remitted with antidepressant therapy, do you consider augmenting with bright light therapy? This treatment modality is accepted for seasonal depression, but a meta-analysis suggests that its efficacy extends to nonseasonal episodes as well. Learn more in this journal CME activity.

Read this CME case to meet a 70-year-old patient who has experienced speech changes that have gradually progressed for 4 years. She has had problems with word-finding, mispronunciations, mild stuttering, and made-up words, and, in the past year, she's begun having functional impairments. Follow along with colleagues through diagnosis and treatment steps.

Is your health system using a collaborative care model to provide high-quality care to patients? Do you know what factors might influence treatment outcomes among adolescents with depression who receive collaborative care? Read this CME journal article to learn more.

How common is illicit drug use among current and former cigarette smokers? If marijuana isn't considered illicit, does that change the prevalence of illicit drug use? Can illicit drug use interfere with smoking abstinence? Learn about these topics in this CME journal article.

Tardive dyskinesia (TD) is an involuntary movement disorder associated with antipsychotic treatment. Because of the serious and potentially irreversible nature of TD, accurate diagnosis is crucial. However, the risk may be underestimated, and diagnosing TD can be challenging, with early signs easily missed. To learn more, read this ACADEMIC HIGHLIGHTS, in which experts review the prevalence, phenomenology, risk factors, and impact of TD, illustrated by case examples, and provide valuable clinical information to guide early recognition and accurate diagnosis.

Descriptions of mixed states can be found in the writings of ancient Greek physicians, and the concept continues to be refined. In this CME activity, join experts as they review the current diagnostic criteria for depressive episodes with mixed features, the risk of developing bipolar disorder in patients with this diagnosis, and recent treatment guidelines.

Are you familiar with mindfulness-based stress reduction (MBSR)? This intervention, which combines meditation and yoga, might appeal to your older patients for relief from depression and worry and may also aid memory. Learn more about MBSR in this journal CME activity.

Consistent evidence has correlated postpartum psychosis with later conversion to bipolar disorder, but nonpsychotic affective disorders are more common in the postpartum period. Could these less severe episodes following childbirth also be markers of underlying bipolar disorder? Read this journal CME research article to learn more.

When you see older patients, do you verify the appropriateness of their prescribed psychotropic drugs? Prescriptions of antidepressants, benzodiazepines, and sedative-hypnotics have increased in this population, even among patients with no mental health diagnosis. Read this journal CME article comparing trends in psychiatry versus primary care.

The risk of a first episode of depression increases during perimenopause and early postmenopause. What is the role of childhood adversity in the onset of major depressive disorder during the menopause transition? Read this journal CME article to learn about new research results.

Experts in the treatment of depression have emphasized the importance of striving for remission. But how do you know when your patient's depression has remitted? Do different standardized scales find similar results? Learn more in this CME article by Zimmerman and coworkers.

Elderly individuals often take multiple medications each day. Age-related changes in pharmacodynamics and pharmacokinetics make this population particularly susceptible to adverse events related to drug interactions. Read this journal CME article to learn about safety issues with antipsychotic medications in these patients.

Depression is common in the elderly, a population often having multiple prescribed treatments due to chronic multimorbidity. Read this CME article to learn how often antidepressants are prescribed and adhered to in this population and how antidepressant adherence affects overall medication adherence.

Patients often take both psychiatric and general medical drugs, prescribed by different practitioners, as well as nonprescription drugs. If you lack complete and up-to-date medication data for your patients, how can you correctly evaluate their clinical status and adjust the medication regimen that you've prescribed? Read this CME article to learn about the need to improve medication reconciliation procedures.

When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out whether increasing the dose provides any greater benefit than waiting longer for patients to respond to the lower dose.

Perinatal depression is common and can have serious implications for both the mother and child. However, the authors of this review found that over 90% of women with antenatal or postpartum depression receive inadequate treatment. Read this CME activity so that your patients won't go undiagnosed and untreated.

Marijuana has been approved in many US states to treat a number of psychiatric conditions, including posttraumatic stress disorder, agitation in Alzheimer’s disease, and Tourette’s disorder. But what is the strength of evidence for the efficacy of marijuana and other cannabinoids for these psychiatric indications? Learn more by reading this CME journal article.

+Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder [Series Home Page]

Pediatric patients with bipolar disorder are at risk for poor long-term outcomes, but with careful screening, clinicians may be able to detect early signs or symptoms. Read this CME Academic Highlights in which experts discuss recognition and diagnosis of bipolar disorder in the pediatric population and options for effective treatment.

How do you select among treatments for bipolar disorder in adolescents? Check out this brief report activity to explore the efficacy and safety of lithium, anticonvulsants, and atypical antipsychotics in the treatment of adolescent bipolar disorder. Plus, receive guidance for monitoring for common adverse effects, such as weight gain and fatigue.

As many as 2 million youths in the US alone could have bipolar disorder. In this CME brief report, get up-to-date on common presentations of pediatric bipolar disorder, DSM-5 diagnostic criteria, and structured interviews and screening tools that can help you detect manic symptomatology.

+Parkinson Disease: Current Trends in Treatment and Unmet Needs [Series Home Page]

Although levodopa is effective for treating Parkinson disease, physicians and patients face significant management challenges related to disease progression. Patients may develop fluctuations in motor symptoms and dyskinesias as well as nonmotor symptoms. Review this CME Brief Report activity to learn about new and emerging treatment options to manage patients’ symptoms.

+Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice [Series Home Page]

Insomnia is often considered a symptom of psychiatric disorders when it actually needs to be addressed as a separate disorder. Read this CME Academic Highlights in which experts discuss ways to evalute patients with insomnia and to safely and effectively implement behavioral and pharmacologic treatments.

Tune in to this podcast as experts discuss 2 patient cases—one involving co-occurring insomnia and depression and another comprising PTSD, substance abuse, insomnia, and nightmares. Drs Benca and Buysse explain how to effectively diagnose and manage these complex cases based on the latest diagnostic criteria and evidence from clinical trials.

Listen to this podcast as experts discuss 2 patient cases focusing on diagnosing and treating co-occurring insomnia and mental illness. The first case features a 32-year-old man with bipolar disorder who is experiencing psychiatric symptoms and poor sleep, and the second case involves a 27-year-old man with schizophrenia who is having auditory hallucinations as well as chronic issues with insomnia.

+Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management [Series Home Page]

How can you help your patients who are experiencing both depression and cognitive dysfunction? Tune in to this CME podcast to hear experts in psychiatry discuss 2 patient cases that illustrate the burden of cognitive impairment in major depressive disorder as well as effective assessment tools and management strategies.

Is cognitive impairment keeping your patients with MDD from achieving full functional recovery? In this Academic Highlights, leading experts in MDD discuss the burden associated with cognitive impairment, effective strategies for assessing cognitive function, and available pharmacologic and nonpharmacologic treatment options.

Pronounced deficits in executive function are found in up to one-third of patients with MDD, and this impairment can keep patients from achieving full functional recovery. In this CME activity, review the evidence regarding the effectiveness of available interventions to improve cognitive dysfunction in patients with MDD.
"

For patients with depression, a return to normal functioning is a key treatment goal. Yet many of these patients demonstrate cognitive impairment even after they reach remission. In this CME activity, learn more about the association between cognitive dysfunction and work functioning, and find information on rating scales that measure functioning.

You know that measuring cognition in your patients with depression is important. But cognitive assessment instruments can be difficult to access, expensive, time consuming, and not available in an electronic format. Read this CME activity to learn about a new free tool.

+Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan? [Series Home Page]

Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for patients with serious mental illness but are underused. Watch this Webcast to learn how to identify patients who may benefit from using LAIs, monitor LAI treatment adherence, and use LAIs safely and effectively in patients with schizophrenia and related disorders.

+What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options [Series Home Page]

Do you know how to treat tardive dyskinesia symptoms? In this new Case and Comment activity, consider the case of John, a 25-year-old project manager diagnosed with bipolar disorder who has begun exhibiting symptoms of uncontrollable movement.

Do you know which of your patients are at risk for developing tardive dyskinesia? Watch this new webcast to learn about how to prevent TD in your patients and new treatment strategies for your patients who have already been diagnosed.

Your patients taking antipsychotics may be at risk for developing tardive dyskinesia. In this new Case and Comment activity, follow Martha, a 60-year-old woman being treated with an antipsychotic medication for her treatment-resistant depression.

How many of your patients achieve remission from depression with their first treatment? In this CME Health Spectrum activity, enter a virtual office to follow 2 patient cases about inadequate response to treatment. Learn as an expert describes strategies based on recent evidence-based guidelines.

Is your patient experiencing involuntary movements of the face, torso, or extremities? It could be tardive dyskinesia, a side effect of antipsychotic medications. Explore this CME Academic Highlights activity to find out who’s at risk for developing tardive dyskinesia and how it can be prevented. Plus, learn about assessment strategies and tools as well as evidence for treatments.

Do you regularly screen for tardive dyskinesia in at-risk patients? Explore this CME activity by a well-known expert for information on rating scales for screening, available diagnostic criteria, assessment tips, and monitoring recommendations.

Many treatment interventions for tardive dyskinesia have been studied, but some have better evidence than others. Read this CME activity to get an expert's perspectives on the evidence for older and newer treatments so that you can minimize abnormal movements in your patients.

What risk factors suggest that patients are more likely to develop tardive dyskinesia (TD)? Can TD symptoms be prevented? Read this CME activity to learn about the prevalence, epidemiology, and prevention of these abnormal movements from an expert.

+Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics? [Series Home Page]

Do you consider long-acting injectable (LAI) antipsychotics when selecting among treatments for schizophrenia? Take part in this CME activity to review the evidence for LAIs vs oral medications and to learn which patients may benefit most from this treatment option. Plus, discover the pharmacokinetic properties of LAIs and barriers to their use.

Binge-eating disorder (BED) is the most common eating disorder but is often overlooked. Consequences of binge eating may include psychological distress, obesity, and metabolic symptoms. Read this CME Supplement to better recognize the signs and symptoms of BED and to provide appropriate evidence-based care.

Do you find the diagnosis and treatment of pediatric bipolar disorder challenging? Read this CME supplement to learn about the phenomenology and differential diagnosis of bipolar disorders in children and adolescents as well as evidence-based pharmacologic and psychotherapeutic interventions. With effective treatment and the support of their families, young patients with bipolar disorder can learn to manage the illness and become independent, healthy adults.

+Improving the Care and Management of Patients With Inadequate Response to Depression Treatment [Series Home Page]

+Enhancing Approaches to the Identification and Management of Pseudobulbar Affect [Series Home Page]